---
title: "GLP-1 birth control and pregnancy: label facts (2026) | GLPMate"
url: https://glpmate.me/blog/glp-1-birth-control-pregnancy-2026
language: en
description: "GLP-1 birth control explained: why Mounjaro and Zepbound can weaken the pill, what Ozempic and Wegovy labels say, and when to stop before pregnancy."
updated: 2026-10-14
---
[Blog](/blog)

# GLP-1 birth control and pregnancy: what the Mounjaro, Zepbound, Ozempic and Wegovy labels say

By [the GLPMate team](/editorial-policy) · Based on FDA prescribing information & peer-reviewed sources · Updated 2026-10-14 · 6 min read

Quick answer

Tirzepatide (Mounjaro, Zepbound) can make birth control pills less effective, so its US labels advise switching to a non-oral method or adding a barrier method for 4 weeks after starting and 4 weeks after each dose increase. Semaglutide (Ozempic, Wegovy) labels carry no such pill warning but advise stopping at least 2 months before a planned pregnancy. Plan both with your prescriber.

## Does Mounjaro or Zepbound make birth control pills less effective?

It can, and this is the part of GLP-1 birth control advice that most often surprises people. Tirzepatide, the medicine in Mounjaro and Zepbound, slows how quickly the stomach empties. A pill taken by mouth may then be absorbed more slowly or less completely.

The labels describe a study in which people took a combined birth control pill after one 5 mg dose of tirzepatide. Peak levels of the pill’s hormones fell by 55% to 66%, overall exposure fell by about 20% to 23%, and the peak arrived 2.5 to 4.5 hours later. The labels also note that this stomach-emptying effect is largest after the first dose and fades over time.

Because of this, both the Zepbound and Mounjaro labels advise people who use oral hormonal contraceptives to either:

- **switch to a non-oral method**, or
- **add a barrier method** (such as condoms) for 4 weeks after starting and for 4 weeks after each dose increase.

According to the labels, hormonal contraceptives that aren’t taken by mouth should not be affected. In practice that usually means options like an implant, IUD, injection, patch or vaginal ring, but which one fits you is a conversation for your prescriber or OB-GYN.

**4 + 4 weeks** Mounjaro and Zepbound US labels: if you take the pill, switch to a non-oral method or add a barrier method for 4 weeks after starting tirzepatide and for 4 weeks after every dose increase (sections 7.2 and 8.3).

### What the 4-week rule looks like during titration

Zepbound starts at 2.5 mg weekly for 4 weeks, and the dose can then go up in 2.5 mg steps after at least 4 weeks on each dose. If your dose goes up every 4 weeks, those backup windows can run back to back for your whole titration and end 4 weeks after your final increase. Our [GLP-1 dose escalation schedule guide](/blog/glp-1-dose-escalation-schedule-2026) shows how those steps usually look.

A few situations the labels don’t spell out are worth asking about directly:

- restarting after a break, if your prescriber has you climb the doses again
- vomiting or diarrhea soon after taking your pill, which is a common question with any oral contraceptive
- a missed or late pill while you’re in a 4-week window

## What do Ozempic and Wegovy labels say about birth control?

The semaglutide labels read differently. Wegovy and Ozempic also slow stomach emptying, and both labels ask for caution or monitoring with oral medicines. But in clinical pharmacology studies, semaglutide did not change levels of ethinyl estradiol or levonorgestrel (common pill hormones) in a clinically significant way. Neither label includes the 4-week backup recommendation that the tirzepatide labels do.

That doesn’t mean contraception stops mattering. Every one of these medicines’ patient guides asks you to tell your prescriber if you’re pregnant or planning to be. UK regulators, for example, advise effective contraception for anyone taking a GLP-1 medicine. If stomach side effects are affecting your pill routine, ask your prescriber or pharmacist what to do.

## How long should you stop Wegovy or Ozempic before pregnancy?

The Wegovy and Ozempic labels advise stopping **at least 2 months before a planned pregnancy**. The reason is washout: semaglutide has a half-life of about one week, and the Wegovy label says it stays in circulation for roughly 5 to 7 weeks after the last dose. Our [GLP-1 half-life calculator](/tools/half-life-calculator) illustrates how levels fall after the last dose, and the [steady-state guide](/learn/glp-1-steady-state-explained) explains why weekly medicines build up and wash out slowly.

For tirzepatide, the US Mounjaro and Zepbound labels **don’t give a specific pre-pregnancy window**. The Zepbound label lists a half-life of about 5 to 6 days. UK guidance, updated in February 2026, suggests stopping tirzepatide at least 1 month and semaglutide at least 2 months before trying to conceive. That is a UK recommendation, not US label wording, so ask your prescriber what applies to you.

### If you take Ozempic or Mounjaro for type 2 diabetes

The diabetes labels are worded differently. They say the medicine should be used in pregnancy only if the potential benefit justifies the potential risk to the baby. They also note that poorly controlled diabetes in pregnancy carries its own risks. Don’t simply stop: your diabetes team will plan how to keep blood sugar in range before and during pregnancy.

## What if you get pregnant while taking a GLP-1?

Call your prescriber and your OB-GYN promptly. The Zepbound and Wegovy labels say weight loss offers no benefit in pregnancy and may harm the baby, so treatment for weight reduction should be stopped once pregnancy is recognized. Human data are still too limited to rule out risks, and animal studies raised concerns. The Zepbound and Wegovy labels both list pregnancy registries, and your clinician can tell you how to take part.

If you find out you were exposed early, there is some early evidence to discuss with your doctor. In a large multinational study of women with type 2 diabetes (Cesta et al., 2024), early-pregnancy GLP-1 exposure was not linked to a large increase in major birth defects compared with insulin. The estimates were imprecise and the data predate tirzepatide, so this is not a guarantee of safety.

## Can you breastfeed on Mounjaro, Zepbound, Ozempic or Wegovy?

The US labels say data are limited:

- **Tirzepatide:** in a single-dose study of 11 breastfeeding women, the drug was undetectable in most milk samples, and the total amount found was under 0.02% of the dose. There are no data on effects in babies or on milk supply.
- **Semaglutide injections (Ozempic, Wegovy):** there are no human milk data.
- **Wegovy tablets:** breastfeeding is not recommended, because an ingredient in the tablet appears in breast milk.

UK guidance is stricter and advises against taking GLP-1 medicines while breastfeeding. Make this decision with your doctor and your baby’s pediatrician.

## Can GLP-1 weight loss affect fertility?

For some people it may, especially with polycystic ovary syndrome (PCOS), where irregular cycles are common. A 2023 meta-analysis of 11 small trials in 840 women with PCOS found GLP-1 medicines were associated with a higher natural pregnancy rate and more regular cycles. They did not raise total or IVF pregnancy rates.

The practical point: if your cycles were irregular before treatment, don’t assume they’ll stay that way. If you don’t want to become pregnant, use reliable contraception. If you do, plan the timing with your care team.

## How to plan with your prescriber

### Before starting

- Say which contraception you use, especially if it’s a pill.
- Mention if you’re trying to conceive, might be soon, or are breastfeeding.

### During titration

- Note the dates of each dose increase so you know when each 4-week window ends.
- Ask what to do if you vomit, have diarrhea, or miss a pill.

### Before trying to conceive

- Agree on when to stop and what replaces it, especially if you have diabetes.
- Talk about weight and nutrition goals for pregnancy; the labels note that appropriate weight gain is recommended in pregnancy, including for people with obesity.

## When to call your doctor

- A positive pregnancy test or a missed period while on a GLP-1
- Unprotected sex during a 4-week window on tirzepatide (ask about emergency contraception)
- Vomiting or diarrhea that stops you from keeping your pill or fluids down
- Severe stomach pain that won’t go away, with or without vomiting
- Signs of an allergic reaction, such as swelling of the face or throat or trouble breathing (call emergency services)
- Any concerns about a breastfed baby

## The bottom line

Tirzepatide and the pill need a plan for the first 4 weeks and after every dose increase. Semaglutide labels don’t ask for backup, but they do ask you to stop at least 2 months before a planned pregnancy. GLPMate’s dose log keeps a dated record of every increase, and the [doctor report](/glp-1-doctor-report) brings that history to your appointment.

This article is educational only and not medical advice. It is not a substitute for guidance from your prescriber or OB-GYN, who know your health history and contraception needs.

FAQ

## FAQ

### Does Mounjaro or Zepbound make birth control pills less effective?

It can. Tirzepatide slows stomach emptying, which lowered pill hormone levels in a study, so the US labels advise switching to a non-oral method or adding a barrier method such as condoms for 4 weeks after starting and for 4 weeks after each dose increase. Non-oral hormonal methods are not expected to be affected. Ask your prescriber which option suits you.

### Do I need backup birth control on Ozempic or Wegovy?

The US semaglutide labels do not carry the 4-week backup recommendation that tirzepatide labels do; in clinical pharmacology studies, semaglutide did not meaningfully change pill hormone levels. You still need reliable contraception if you don't want to become pregnant, and you should ask what to do if vomiting or diarrhea could affect your pill.

### How long should I stop Wegovy or Zepbound before trying to get pregnant?

The Wegovy and Ozempic labels advise stopping at least 2 months before a planned pregnancy because semaglutide stays in the body for weeks. The US Mounjaro and Zepbound labels give no specific window, while UK guidance suggests at least 1 month for tirzepatide. Make the plan with your prescriber, especially if you have diabetes.

### Can I breastfeed while taking Zepbound, Mounjaro, Ozempic or Wegovy?

US labels say data are limited. In a small tirzepatide study, little or no drug reached breast milk, but effects on babies are unknown; there are no human milk data for semaglutide injections, and breastfeeding is not recommended with Wegovy tablets. UK guidance advises against using GLP-1 medicines while breastfeeding, so decide with your doctor and your baby's pediatrician.

## Sources

1. Zepbound (tirzepatide) US Prescribing Information and Medication Guide, Eli Lilly — DailyMed, revised 08/2026 — sections 2.1 (dose escalation every 4 weeks), 7.2 and 8.3 (switch to a non-oral method or add a barrier method for 4 weeks after starting and after each dose increase; non-oral hormonal methods not expected to be affected), 8.1 (stop when pregnancy is recognized; weight loss not recommended in pregnancy), 8.2 (lactation study), 12.2/12.3 (pill hormone levels, half-life about 5–6 days, steady state after 4 weeks)
2. Mounjaro (tirzepatide) US Prescribing Information, Eli Lilly — DailyMed, revised 08/2026 — same 4-week oral contraceptive advice (7.2, 8.3, 17); pregnancy use only if benefit justifies risk, with diabetes-control considerations (8.1); lactation data (8.2)
3. Wegovy (semaglutide) injection and tablets US Prescribing Information, Novo Nordisk — DailyMed, revised 06/2026 — no contraceptive warning; no clinically significant change in ethinyl estradiol or levonorgestrel levels (7.2, 12.3); stop at least 2 months before a planned pregnancy (8.3); stop when pregnant if used for weight reduction (8.1); breastfeeding not recommended with the tablets (8.2); semaglutide present about 5–7 weeks after the last dose (12.3)
4. Ozempic (semaglutide) injection US Prescribing Information, Novo Nordisk — DailyMed — no clinically relevant effect on oral medication absorption (7.2); stop at least 2 months before a planned pregnancy because of the long washout (8.3); no human milk data (8.2)
5. MHRA (UK), GLP-1 medicines for weight loss and diabetes: what you need to know — updated 5 February 2026 — UK guidance differs from US labels: at least 1 month off tirzepatide and 2 months off semaglutide before trying to conceive; not for use while breastfeeding; contraception advised for everyone on GLP-1 medicines
6. Cesta et al., JAMA Internal Medicine 2024 — periconceptional second-line diabetes medicines and major congenital malformations (multinational cohort) — in women with type 2 diabetes, early-pregnancy GLP-1 receptor agonist exposure was not linked to a large increase in major malformations versus insulin; estimates imprecise; data predate tirzepatide
7. Zhou et al., BMC Endocrine Disorders 2023 — meta-analysis of 11 RCTs (840 women with PCOS) — GLP-1 receptor agonists were associated with a higher natural pregnancy rate and more regular cycles, but not with higher total or IVF pregnancy rates

Sources checked: October 14, 2026

This article is educational and is not medical advice, diagnosis or treatment. Medication decisions — including dose changes and what to do after a missed dose — belong with your prescriber. If you experience severe symptoms, seek medical care.

## Keep reading

[GLP-1 dose escalation schedule ](/blog/glp-1-dose-escalation-schedule-2026)[GLP-1 half-life calculator ](/tools/half-life-calculator)[GLP-1 steady state explained ](/learn/glp-1-steady-state-explained)

## Start your GLP-1 journey with a companion that listens.

Free to start. iOS & Android.

[ Download on the **App Store** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=blog-glp-1-birth-control-pregnancy-2026&adj_redirect_android=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_macos=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235&adj_redirect_windows=https%3A%2F%2Fapps.apple.com%2Fapp%2Fid6788548235) [ GET IT ON **Google Play** ](https://glpmate.go.link?adj_t=22klhq12&adj_campaign=blog-glp-1-birth-control-pregnancy-2026&adj_redirect_ios=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_macos=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate&adj_redirect_windows=https%3A%2F%2Fplay.google.com%2Fstore%2Fapps%2Fdetails%3Fid%3Dapp.eleutheromania.glpmate)